Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-15 Sale | 2022-12-19 4:45 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 445 | $10.9 | $4,851 | 10,753 (Direct) | View |
| 2022-12-01 Sale | 2022-12-02 6:36 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 8,600 | $13.01 | $111,886 | 11,198 (Direct) | View |
| 2022-03-01 Sale | 2022-03-03 5:04 pm | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 2,300 | $17.2 | $39,560 | 11,198 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-19 Option Award | 2022-12-21 4:36 pm | 2023-12-19 2032-12-19 | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 14,400 | $0 | 25,153 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 6:36 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 8,600 | $1.42 | 11,198 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-02 6:36 pm | 2014-01-01 2023-01-01 | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 8,600 | $0 | 11,198 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-03 5:04 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 2,300 | $4.73 | 11,198 (Direct) | View |
| 2022-03-01 Exercise | 2022-03-03 5:04 pm | 2013-03-01 2022-03-01 | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 2,300 | $0 | 11,198 (Direct) | View |
| 2021-12-14 Option Award | 2021-12-16 5:16 pm | 2022-12-14 2031-12-14 | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 17,550 | $0 | 22,898 (Direct) | View |
| 2021-03-18 Exercise | 2021-03-22 4:19 pm | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 4,500 | $3.51 | 5,348 (Direct) | View |
| 2021-03-18 Exercise | 2021-03-22 4:19 pm | 2012-03-21 2021-03-21 | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 4,500 | $0 | 5,348 (Direct) | View |
| 2020-12-15 Option Award | 2020-12-17 4:41 pm | 2021-12-15 2030-12-15 | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 30,000 | $0 | 30,000 (Direct) | View |
| 2020-12-03 Option Award | 2020-12-07 4:24 pm | 2020-12-03 2023-08-08 | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 5,000 | $0 | 5,000 (Direct) | View |
| 2020-02-21 Option Award | 2020-02-25 4:49 pm | 2020-02-21 2024-12-22 | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 2,800 | $0 | 2,800 (Direct) | View |
| 2020-02-14 Option Award | 2020-02-19 5:13 pm | 2020-02-14 2024-12-22 | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec. Director, Finance - PAO | 4,900 | $0 | 4,900 (Direct) | View |
Ownership | 2020-01-17 09:05 am | N/A N/A | BIOCRYST PHARMACEUTICALS INC | BCRX | Jones Michael L Exec Director, Finance - PAO | 0 | $0 | 96,848 (Direct) | View |